The global arterial cannula market size was accounted for USD 33.80 million in 2024, grew to USD 35.43 million in 2025 and is projected to surpass around USD 54.12 million by 2034, representing a CAGR of 4.82% between 2025 and 2034. The North America arterial cannula market size is calculated at USD 13.26 million in 2024 and is expected to grow at a CAGR of 4.81% during the forecast year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Arterial Cannula Industry Impact
5.2. COVID-19 Impact Assessment for the Industry
5.3. COVID-19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Arterial Cannula Market Revenue and Volume, by Size, 2025-2034
8.1.1 14-16 Fr
8.1.1.1. Market Revenue and Volume Forecast (2022-2034)
8.1.2. 17-19 Fr
8.1.2.1. Market Revenue and Volume Forecast (2022-2034)
8.1.3. 20-22 Fr
8.1.3.1. Market Revenue and Volume Forecast (2022-2034)
8.1.4. 23-25 Fr
8.1.4.1. Market Revenue and Volume Forecast (2022-2034)
8.1.5. 26-28 Fr
8.1.5.1. Market Revenue and Volume Forecast (2022-2034)
8.1.6. 29- 31 Fr
8.1.6.1. Market Revenue and Volume Forecast (2022-2034)
8.1.7. 32-34 Fr
8.1.7.1. Market Revenue and Volume Forecast (2022-2034)
8.1.8. 35-36 Fr
8.1.8.1. Market Revenue and Volume Forecast (2022-2034)
9.1. Arterial Cannula Market Revenue and Volume, by Application, 2025-2034
9.1.1. Cardiopulmonary Bypass Surgery
9.1.1.1. Market Revenue and Volume Forecast (2022-2034)
9.1.2. Extracorporeal Membrane Oxygenation (ECMO)
9.1.2.1. Market Revenue and Volume Forecast (2022-2034)
9.1.3. Others
9.1.3.1. Market Revenue and Volume Forecast (2022-2034)
10.1. Arterial Cannula Market Revenue and Volume, by End-use, 2025-2034
10.1.1. Hospitals
10.1.1.1. Market Revenue and Volume Forecast (2022-2034)
10.1.2. Ambulatory Surgical Centers
10.1.2.1. Market Revenue and Volume Forecast (2022-2034)
10.1.3. Others
10.1.3.1. Market Revenue and Volume Forecast (2022-2034)
11.1. North America
11.1.1. Market Revenue and Volume Forecast, by Size (2022-2034)
11.1.2. Market Revenue and Volume Forecast, by Application (2022-2034)
11.1.3. Market Revenue and Volume Forecast, by End-use (2022-2034)
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by Size (2022-2034)
11.1.4.2. Market Revenue and Volume Forecast, by Application (2022-2034)
11.1.4.3. Market Revenue and Volume Forecast, by End-use (2022-2034)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by Size (2022-2034)
11.1.5.2. Market Revenue and Volume Forecast, by Application (2022-2034)
11.1.5.3. Market Revenue and Volume Forecast, by End-use (2022-2034)
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Size (2022-2034)
11.2.2. Market Revenue and Volume Forecast, by Application (2022-2034)
11.2.3. Market Revenue and Volume Forecast, by End-use (2022-2034)
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by Size (2022-2034)
11.2.4.2. Market Revenue and Volume Forecast, by Application (2022-2034)
11.2.4.3. Market Revenue and Volume Forecast, by End-use (2022-2034)
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by Size (2022-2034)
11.2.5.2. Market Revenue and Volume Forecast, by Application (2022-2034)
11.2.5.3. Market Revenue and Volume Forecast, by End-use (2022-2034)
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by Size (2022-2034)
11.2.6.2. Market Revenue and Volume Forecast, by Application (2022-2034)
11.2.6.3. Market Revenue and Volume Forecast, by End-use (2022-2034)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by Size (2022-2034)
11.2.7.2. Market Revenue and Volume Forecast, by Application (2022-2034)
11.2.7.3. Market Revenue and Volume Forecast, by End-use (2022-2034)
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by Size (2022-2034)
11.3.2. Market Revenue and Volume Forecast, by Application (2022-2034)
11.3.3. Market Revenue and Volume Forecast, by End-use (2022-2034)
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by Size (2022-2034)
11.3.4.2. Market Revenue and Volume Forecast, by Application (2022-2034)
11.3.4.3. Market Revenue and Volume Forecast, by End-use (2022-2034)
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by Size (2022-2034)
11.3.5.2. Market Revenue and Volume Forecast, by Application (2022-2034)
11.3.5.3. Market Revenue and Volume Forecast, by End-use (2022-2034)
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by Size (2022-2034)
11.3.6.2. Market Revenue and Volume Forecast, by Application (2022-2034)
11.3.6.3. Market Revenue and Volume Forecast, by End-use (2022-2034)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by Size (2022-2034)
11.3.7.2. Market Revenue and Volume Forecast, by Application (2022-2034)
11.3.7.3. Market Revenue and Volume Forecast, by End-use (2022-2034)
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by Size (2022-2034)
11.4.2. Market Revenue and Volume Forecast, by Application (2022-2034)
11.4.3. Market Revenue and Volume Forecast, by End-use (2022-2034)
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by Size (2022-2034)
11.4.4.2. Market Revenue and Volume Forecast, by Application (2022-2034)
11.4.4.3. Market Revenue and Volume Forecast, by End-use (2022-2034)
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by Size (2022-2034)
11.4.5.2. Market Revenue and Volume Forecast, by Application (2022-2034)
11.4.5.3. Market Revenue and Volume Forecast, by End-use (2022-2034)
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by Size (2022-2034)
11.4.6.2. Market Revenue and Volume Forecast, by Application (2022-2034)
11.4.6.3. Market Revenue and Volume Forecast, by End-use (2022-2034)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by Size (2022-2034)
11.4.7.2. Market Revenue and Volume Forecast, by Application (2022-2034)
11.4.7.3. Market Revenue and Volume Forecast, by End-use (2022-2034)
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by Size (2022-2034)
11.5.2. Market Revenue and Volume Forecast, by Application (2022-2034)
11.5.3. Market Revenue and Volume Forecast, by End-use (2022-2034)
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by Size (2022-2034)
11.5.4.2. Market Revenue and Volume Forecast, by Application (2022-2034)
11.5.4.3. Market Revenue and Volume Forecast, by End-use (2022-2034)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by Size (2022-2034)
11.5.5.2. Market Revenue and Volume Forecast, by Application (2022-2034)
11.5.5.3. Market Revenue and Volume Forecast, by End-use (2022-2034)
12.1. Edward Lifesciences
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Medtronic, plc.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. LivaNova plc
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Getinge AB
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Fresenius Medical Care
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. BD
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Nipro Corp.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Andocor
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Freelife Medical GmbH
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Surgical Holdings
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample